NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

Concepts

• runcorn
• pharmaceutical products
• cancer
• monoclonal
• nhs framework agreement
• aseptically prepared cytotoxic medicines
• nhs
• medicines
• antibodies
• cytotoxic

Location

Description

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 04f - Labelling and Packaging of Unlicensed Medicines (Specials) - Best Practice Guidance for the NHS - December 2021 Document No. 04f - Labelling and Packaging of Unlicensed Medicines (Specials) - Best Practice Guidance for the NHS - December 2021.pdf Document No. 07a - Aseptically Prepared Specials and Manufacturing Assessments Document No. 07a - Aseptically Prepared Specials and Manufacturing Assessments.xlsx Document No. 04a - Conformance Specification Document No. 04a - Conformance Specification.doc Document No. 04e - Management of Supply Issues Document No. 04e - Management of Supply Issues.pdf Document No. 04g - Standard Protocol for Deriving and Assessment of Stability Part 1 Aseptic Preparations (Small Molecules) Document No. 04g - Standard Protocol for Deriving and Assessment of Stability Part 1 Aseptic Preparations (Small Molecules).pdf Document No. 01 - Invitation to offer covering letter 5686 Document No. 01 - Invitation to offer covering letter 5686.docx Document No. 02 - Terms of offer Document No. 02 - Terms of offer.docx Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.docx Document No. 04b - Performance Specification Document No. 04b - Performance Specification.doc Document No. 04c - Management Information - Template Document No. 04c - Management Information - Template.xlsx Document No. 04d - KPI Reporting Tool Document No. 04d - KPI Reporting Tool.xlsx Document No. 05 - Offer Schedule Document No. 05 - Offer Schedule.xlsx Document No. 07b - Basket of Goods Document No. 07b - Basket of Goods.xlsx Document No. 09 - Participating Authorities Document No. 09 - Participating Authorities.xls Document No. 04h - Standard Protocol for Deriving and Assessment of Stability Part 2 Biopharmaceuticals Document No. 04h - Standard Protocol for Deriving and Assessment of Stability Part 2 Biopharmaceuticals.pdf Document No. 04j - Protocols for the Integrity Testing of Syringes Document No. 04j - Protocols for the Integrity Testing of Syringes.pdf Document No. 06b - Call-Off Order Form Document No. 06b - Call-Off Order Form.docx Document No. 08 - Confidential information schedule Document No. 08 - Confidential information schedule.xls Document No. 06 - Form of offer Document No. 06 - Form of offer.doc Document No. 06a - Call-Off Award Procedure Document No. 06a - Call-Off Award Procedure.doc